Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’
Sophia Weiner(Institute of Neurobiology), Johan Gobom(Sahlgrenska University Hospital), Fernando González‐Ortiz(Sahlgrenska University Hospital), Tuomas Rauramaa(University of Eastern Finland), Ville Leinonen(University of Eastern Finland), Nesrine Rahmouni(McGill University), Mathias Sauer(Sahlgrenska University Hospital), Stijn Servaes(Douglas Mental Health University Institute), Laia Montoliu‐Gaya(University of Gothenburg), Cécile Tissot(Hirslanden Clinique des Grangettes), Henrik Zetterberg(Queen Mary University of London), Pedro Rosa‐Neto(Montreal Neurological Institute and Hospital), Nicholas J. Ashton(King's College London), Mikko Hiltunen(Kuopio University Hospital), Andréa L. Benedet(University of Gothenburg), Jenna Stevenson(McGill University), Joseph Therriault(Douglas Mental Health University Institute), Kaj Blennow(University of Gothenburg), Joel Simrén(Sahlgrenska University Hospital)
Cited by 4
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
A Practical Guide to Immunoassay Method Validation
|Frontiers in Neurology|2015|541